ClinicalTrials.gov
ClinicalTrials.gov Menu

Sample Collection From Melanoma Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00507325
Recruitment Status : Active, not recruiting
First Posted : July 26, 2007
Last Update Posted : September 13, 2017
Sponsor:
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

Brief Summary:
The goal of this laboratory research study is to collect blood and tumor samples from patients with malignant melanoma. Researchers want to store these samples in a secure and confidential laboratory at M. D. Anderson. Researchers will use the information that is learned in this study to help find ways to improve treatment for melanoma and other cancers.

Condition or disease Intervention/treatment
Melanoma Procedure: Blood Sample Procedure: Tumor Sample

  Show Detailed Description

Study Type : Observational
Estimated Enrollment : 200 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Blood and Tumor Sample Collection From Patients With Malignant Melanoma for Long Term Storage
Actual Study Start Date : June 2006
Estimated Primary Completion Date : June 2019
Estimated Study Completion Date : June 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Melanoma
U.S. FDA Resources

Group/Cohort Intervention/treatment
Blood Sample + Tumor Sample
Blood samples will be collected. Tumor samples will be collected using a small needle, a punch knife, or a small surgery.
Procedure: Blood Sample
Blood samples will be collected.
Procedure: Tumor Sample
Tumor samples will be collected using a small needle, a punch knife, or a small surgery.



Primary Outcome Measures :
  1. Collection and long-term collection of blood and tumor samples from patients with malignant melanoma for future biological and/or surrogate marker studies. [ Time Frame: 6 Years ]

Biospecimen Retention:   Samples With DNA
Patients will provide blood and tumor samples to help researchers learn about melanoma and other cancers.


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Study participants with a diagnosis of malignant melanoma.
Criteria

Inclusion Criteria:

  1. Patients with a suspected or confirmed diagnosis of malignant melanoma. These include patients with melanoma of the soft part, spindle-cell neoplasm consistent with melanoma and choroidal melanoma.
  2. Patients who are willing to consent for this protocol.

Exclusion Criteria: None


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00507325


Locations
United States, Texas
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030
Sponsors and Collaborators
M.D. Anderson Cancer Center
Investigators
Principal Investigator: Kevin B. Kim, MD M.D. Anderson Cancer Center

Additional Information:
Responsible Party: M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier: NCT00507325     History of Changes
Other Study ID Numbers: 2005-0466
First Posted: July 26, 2007    Key Record Dates
Last Update Posted: September 13, 2017
Last Verified: September 2017

Keywords provided by M.D. Anderson Cancer Center:
Malignant Melanoma
Blood Sample
Tumor Sample
Long-term storage
Sample Collection

Additional relevant MeSH terms:
Melanoma
Neuroendocrine Tumors
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Nerve Tissue
Nevi and Melanomas